Diabetic Management Status of Type 2 Diabetic Outpatients at Maharat Nakhon Ratchasima Hospital: Diabetic Registry Project
Main Article Content
Abstract
Objective: The aim of this study is to demonstrate a current status of diabetic management, microvascular and macrovascular complications of the patients with type 2 diabetes mellitus at Maharat Nakhon Ratchasima hospital. Materials & Methods: A cross-sectional, hospital-based diabetes registry was carried out from the data obtained between April to December 2003 during diabetic care of diabetic patients in diabetic clinic at Maharat Nakhon Ratchasima Hospital. Results: A total of 1,066 diagnosed diabetic patients, there were 1,000 patients with type 2 diabetes mellitus registered in this study, which consisted of 273 males and 727 females. The mean age was 59.4+10.9 years and the mean duration of diabetes mellitus was 8.2+6.8 years. We found only 37.6% of these patients achieved glycemic control of fasting plasma glucose under 130 mg/dL and 31.9% had an HbA1c level less than 7%. The overall prevalence of dyslipidemia, hypertension, and obesity (body mass index, BMI >25 kg/m2) found in this population were 47.7%, 60.7%, and 47.4% respectively. Our analysis also found that diabetic nephropathy is the most common complication, accounting for 33.6% of the patients followed by retinopathy 17.1%, ischemic heart disease 6.1% and cerebrovascular disease 3.4% respectively. Conclusion: The higher mean age of 59 years and longer duration 8.2 years of diabetes contributed to a high prevalence of diabetic complications, especially microvascular complication. Less than half of patients had good glycemic control combined with other metabolic control of blood pressure and lipid profile. Getting an annual check up is an important strategy for early identification and management of diabetic complication.
Article Details
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complication: estimates and projection to the year 2010. Diabet Med 1997; 14 (Suppl 5): S1-85.
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projection. Diabetes Care 1998; 21: 1414-31.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
Aekplakorn W, Stolk RP, Neal B, Suriyawongpaisal P, Chongsuvivatwong V, Cheepudomwit S, et al. The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care 2003; 26: 2758-63.
Williams R,Van Gaal L, Lucioni C; CODE-2 Advisory Board. Assessing the impact of complications on the cost of Type II diabetes. Diabetologia. 2002; 45: S13-7.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: S5-20.
Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-82.
American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28 (Supp 1): S4-36.
Gilmer TP, O’Connor PJ, Manning WG, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care 1997; 20: 1847-53.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28.
Rawdaree P, Ngarmukos C, Deerochanawong C, Suwanwalaikorn S, Chetthakul T, Krittiyawong S, et al. Thailand diabetes registry (TDR) project: clinical status and long term vascular complications in diabetic patients. J Med Assoc Thai 2006; 89 (Suppl 1): S1-9.
Chuang LM, Tsai ST, Huang BY, Tai TY; Diabcare-Asia 1998 Study Group. The status of diabetes control in Asia: a cross-sectional survey of 24,317 patients with diabetes mellitus in 1998. Diabet Med 2002; 19: 978-85
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
Reichard P, Britz A, Cars I, Nilsson BY, Sobocinsky-Olsson B, Rosenqvist U. The Stockholm Diabetes Intervention Study (SDIS): 18 months’ results. Acta Med Scand 1988; 224: 115-22.